Comparison of two regimens of fluconazol in treatment of cutaneous lieshmaniasis
Phase 2
- Conditions
- Cutaneous leishmaniasisCutaneous leishmaniasis.
- Registration Number
- IRCT138710221542N1
- Lead Sponsor
- Shiraz University of Medical Scienses
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 94
Inclusion Criteria
age over 12 years, positive PCR for leishmanisis and no treatment in two months ago, duration of disease is lower than 4 months.
Exclusion criteria: pregnancy, breast feeding, possibility of pregnancy in future, number of lesion over ten, history of liver disease and high BUN or Cr.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reepithelialization. Timepoint: every two week. Method of measurement: observation.;Size of lesion. Timepoint: every two week. Method of measurement: with ruler.;Induration of lesion. Timepoint: every two week. Method of measurement: physical examination.
- Secondary Outcome Measures
Name Time Method Rising of liver enzyme, BUN and Cr. Timepoint: every two week. Method of measurement: Blood sample and laboratory measurment.;Nausea and vomitting. Timepoint: every two week. Method of measurement: History.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie fluconazole's efficacy against Leishmania parasites in cutaneous leishmaniasis?
How does fluconazole compare to pentavalent antimonials in treating cutaneous leishmaniasis in Phase II trials?
Which biomarkers predict response to fluconazole in cutaneous leishmaniasis patients with specific Leishmania species?
What are the adverse event profiles of 200 mg vs. 400 mg fluconazole regimens for cutaneous leishmaniasis?
Are combination therapies with fluconazole and miltefosine more effective for cutaneous leishmaniasis than monotherapy?